1. MARKET INTRODUCTION 1.1 Market Definition 12 1.2 Objective of the Study 12 1.3 Limitation 12 1.4 Stakeholders 13 1.5 Currency used in the Report 13 2. RESEARCH METHODOLOGY OR ASSUMPTION 14 2.1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14 2.1.1 Main objective of the Needle Free Drug Delivery Devices Market Study 15 3. REGULATORY FRAMEWORK AND KEY DEVELOPMENT 16 3.1 General Overview 16 3.1.1 North America 16 3.1.2 Europe 17 4. INDUSTRY PERFORMANCE 18 5. EXECUTIVE SUMMARY 20 6. MARKET OVERVIEW 23 6.1 Introduction 23 6.2 Market Dynamics 24 6.2.1 Market Trend & Drivers 24 6.2.2 Rising Prevalence of Chronic and Lifestyle Diseases 24 6.2.3 Inclination Towards Self Administration of Drugs 26 6.2.4 Growing Technological Advancements in the Devices 27 6.3 Market Challenges 27 6.3.1 Ambiguity in the Specifications of Needle Free Devices 27 6.3.2 Limitations associated with Micro Needle Patches 28 6.4 Market Opportunities 28 6.4.1 Increase in the number of start-ups and Investments 28 6.4.2 Growing Adoption in Emerging Countries of Asia-Pacific Region 30 7. KEY MARKET INDICATORS 31 7.1 General Overview 31 7.1.1 Demand and Supply Side Analysis 31 7.1.1.1 Top Winning Strategies 32 7.1.1.1.1 Top Product launches 32 7.1.1.1.2 Top Business Expansions & Investments 33 7.1.1.1.3 Top Acquisition and Collaborations 34 7.1.2 Needle-free injection technology manufacturing process value chain 35 8. MARKET INSIGHTS BY PRODUCT TYPE (2018-25) 37 8.1 General Overview 37 8.1.1 Prefilled needle-free injection systems 38 8.1.2 Fillable needle-free injection systems 39 9. MARKET INSIGHTS BY TECHNOLOGY (2018-25) 41 9.1 General Overview 41 9.1.1 Jet Injectors 42 9.1.2 Transdermal Drug Delivery Systems 43 9.1.3 Inhaler Technology 44 10. MARKET INSIGHTS BY APPLICATION TYPE (2018- 2025) 46 10.1 General Overview 46 10.1.1 Insulin Delivery 47 10.1.2 Vaccination 48 10.1.3 Pediatric Injections 49 10.1.4 Pain Management 50 11. MARKET INSIGHTS BY INJECTION METHODS 51 11.1 General Overview 51 11.1.1 Powder injections 52 11.1.2 Liquid injections 53 11.1.3 Depot or Projectile Injection 54 12. MARKET INSIGHTS BY SOURCE POWER 55 12.1 General Overview 55 12.1.1 Spring Loaded Jet Injector 56 12.1.2 Gas Powered Jet Injector 57 12.1.3 Battery Powered Jet Injector 58 13. MARKET INSIGHTS BY REGION 59 13.1 General Overview 59 13.1.1 North America Needle-Free Drug Delivery Market (2018-2025) 60 13.1.1.1 North America Needle Free Drug Delivery Market, by Product 62 13.1.1.2 North America Needle-Free Drug Delivery Market, by Technology 62 13.1.1.3 North America Needle-Free Drug Delivery Device Market, by Application 63 13.1.1.4 North America Needle-Free Drug Delivery Market, by Injection Method 63 13.1.1.5 North America Needle Free Drug Delivery Device Market by, Source of Power 64 13.1.2 Europe Needle-Free Drug Delivery Device Market (2018-2025) 64 13.1.2.1 Europe Needle-Free Drug Delivery Device Market, by Product 68 13.1.2.2 Europe Needle-Free Drug Delivery Device Market, by Technology 68 13.1.2.3 Europe Needle-Free Drug Delivery Device Market, by Application 69 13.1.2.4 Europe Needle Free Drug Delivery Device Market, by Injection Method 69 13.1.2.5 Europe Needle-Free Drug Delivery Device Market, by Source of Power 70 13.1.3 Asia Pacific Needle-Free Drug Delivery Device Market (2018-2025) 70 13.1.3.1 Asia Pacific Needle-Free Drug Delivery Device Market, by Product 74 13.1.3.2 Asia Pacific Needle-Free Drug Delivery Device Market, by Technology 74 13.1.3.3 Asia Pacific Needle Free Drug Delivery Device Market, by Application 75 13.1.3.4 Asia Pacific Needle-Free Drug Delivery Device Market, by Injection Method 75 13.1.3.5 Asia Pacific Needle-Free Drug Delivery Device Market, by Source of Power 76 13.1.4 Rest of World Needle-Free Drug Delivery Device Market (2018-2025) 76 13.1.4.1 RoW Needle-Free Drug Delivery Device Market, by Product 78 13.1.4.2 RoW Needle-Free Drug Delivery Device Market, by Technology 78 13.1.4.3 RoW Needle-Free Drug Delivery Device Market, by Application 79 13.1.4.4 RoW Needle Free Needle-Free Device Market, by Injection Method 79 13.1.4.5 RoW Needle-Free Drug Delivery Device Market by Source of Power 80 14. COMPETITIVE SCENARIO 81 14.1 Porter’s Five forces analysis 81 14.1.1 Bargaining power of Buyer 81 14.1.2 Bargaining power of Supplier 82 14.1.3 The threat of new entrants 82 14.1.4 Availability of Substitute 83 14.1.5 Industry Rivalry 83 14.2 Global Needle-Free Drug Delivery Market Share Analysis, 2017 84 15. COMPANY PROFILES 85 15.1 Antares Pharma, Inc. 85 15.1.1 Key Facts 85 15.1.2 Business Description 85 15.1.3 Key Product/Services Offerings 86 15.1.4 SWOT Analysis 87 15.1.5 Key Financials 87 15.1.6 Recent Developments 89 15.1.7 Funding 89 15.2 Consort Medical 90 15.2.1 Key Facts 90 15.2.2 Business Description 90 15.2.3 Key Product/Services Offerings 91 15.2.4 SWOT Analysis 92 15.2.5 Key Financials 92 15.2.6 Revenue Split 93 15.2.7 Recent Developments 94 15.3 Crossject Société Anonyme 95 15.3.1 Key Facts 95 15.3.2 Business Description 95 15.3.3 SWOT Analysis 96 15.3.4 Recent Developments 96 15.3.5 Funding 96 15.4 Inovio Pharmaceuticals 97 15.4.1 Key Facts 97 15.4.2 Business Description 97 15.4.3 SWOT Analysis 99 15.4.4 Key Financials 100 15.4.5 Revenue Split 101 15.4.6 Recent Developments 101 15.4.7 Funding 101 15.5 Injex Pharma 102 15.5.1 Key Facts 102 15.5.2 Business Description 102 15.5.3 Key Product/Services Offerings 102 15.5.4 SWOT Analysis 103 15.6 Medical International Technology 104 15.6.1 Key Facts 104 15.6.2 Business Description 104 15.6.3 Key Product/Services Offerings 105 15.6.4 SWOT Analysis 105 15.6.5 Key Financials 106 15.6.6 Recent Developments 107 15.7 Zosano Pharma 108 15.7.1 Key Facts 108 15.7.2 Business Description 108 15.7.3 Key Product/Services Offerings 109 15.7.4 SWOT Analysis 109 15.7.5 Key Financials 110 15.7.6 Recent Developments 111 15.8 Valeritas 112 15.8.1 Key Facts 112 15.8.2 Business Description 112 15.8.3 Key Product/Services Offerings 113 15.8.4 SWOT Analysis 113 15.8.5 Key Financials 114 15.8.6 Revenue Split 115 15.8.7 Recent Developments 115 15.8.8 Funding 115 15.9 3M 116 15.9.1 Key Facts 116 15.9.2 Business Description 116 15.9.3 Key Product/Services Offerings 117 15.9.4 SWOT Analysis 118 15.9.5 Key Financials 118 15.9.6 Revenue Split 119 15.9.7 Recent Developments 120 15.9.8 Funding 120 15.10 PharmaJet 121 15.10.1 Key Facts 121 15.10.2 Business Description 121 15.10.3 Key Product/Services Offerings 122 15.10.4 SWOT Analysis 122 15.10.5 Recent Developments 123 15.10.6 Funding 123

FIG. 1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14 FIG. 2 Global Countries with most Adults Living with Diabetes, 2017 20 FIG. 3 Global Needle Free Drug Delivery Device Market 2019-2025 (US$ Million) 21 FIG. 4 Facts about Chronic Disease in the US, 2016 25 FIG. 5 Frequency of Needle Stick Injuries, by Devices 25 FIG. 6 Process for Self-Administration of Medicines (SAMS) 26 FIG. 7 Global Top Country, by Start-Up County 2017 29 FIG. 8 Global Funding, by Region 2016 & 2017 (US$ billion) 29 FIG. 9 Health Expenditure Per Capita in Asia-Pacific, by Country 2015 (USD PPP) 30 FIG. 10 Needle-free Injection Technology Manufacturing Process 35 FIG. 11 Global Needle-Free Drug Delivery Device Market Share, by Product Type, 2018 & 2025 (%) 37 FIG. 12 Global Needle-Free Drug Delivery Device Market, by Product 2018-25 (US$ Million) 37 FIG. 13 Global Needle-Free Drug Delivery Device Market Share by Technology, 2018 & 2025 (%) 41 FIG. 14 Global Needle-Free Drug Delivery Device Market, by Technology, 2018-25 (US$ Million) 41 FIG. 15 Global Needle-Free Drug Delivery Device Market Share, by Application, 2018 & 2025 (%) 46 FIG. 16 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (US$ Million) 46 FIG. 17 Global Needle-Free Drug Delivery Device Market Share by Injection Method, 2018 & 2025 (%) 51 FIG. 18 Global Needle-Free Drug Delivery Device Market by Injection method, 2018-25 (US$ Million) 51 FIG. 19 Global Needle-Free Drug Delivery Device Market Share by Source Power, 2018 & 2025 (%) 55 FIG. 20 Global Needle-Free Drug Delivery Device Market by Source of Power, 2018-25 (US$ Million) 55 FIG. 21 Global Needle-Free Drug Delivery Device Market Share by Region, 2018 & 2025 (%) 59 FIG. 22 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (US$ Million) 59 FIG. 23 Y-o-Y Growth rate of US Healthcare Expenditure (2011-2016), % 60 FIG. 24 Number and % of U.S. Population with Diagnosed Diabetes (2006-2015) 61 FIG. 25 Estimated age-adjusted prevalence of diagnosed diabetes by race/ethnicity and sex among adults aged ≥18 US, 2013–2015 61 FIG. 26 Europe % of population over 65 years old, by Country 2017 65 FIG. 27 Number of people with diabetes in EU28, 2000 and 2017 65 FIG. 28 Europe % of Adult population with Diabetes, by Country 2017 66 FIG. 29 Estimated Incidence rate for all Cancers in Europe, by country, 2018 67 FIG. 30 HIV Prevalence in Asia-Pacific % of Population, by Country 2017 72 FIG. 31 Asia-Pacific Medical Equipment Market US$ Billion (2015-2018) 72 FIG. 32 Ratio of people aged 15-64 to people aged over 65 years in Asia-Pacific, 2015 and 2050 73 FIG. 33 Porter’s Five forces analysis of Global Needle-Free Drug Delivery Device 81 FIG. 34 Patent count of Smart Drug Delivery System 84 FIG. 35 Antares Pharma Inc. SWOT Analysis 87 FIG. 36 Key Financials of Antares Pharma Inc. 87 FIG. 37 Antares Pharma Inc. Revenue Split, 2018 88 FIG. 38 Consort Medical SWOT Analysis 92 FIG. 39 Key Financials of Consort Medical 92 FIG. 40 Consort Medical Revenue Split, 2017 93 FIG. 41 Crossject Société Anonyme SWOT Analysis 96 FIG. 42 Inovio Pharmaceuticals SWOT Analysis 99 FIG. 43 Key Financials of Inovio Pharmaceuticals 100 FIG. 44 Inovio Pharmaceuticals Revenue Split, 2018 101 FIG. 45 Injex Pharma, SWOT Analysis 103 FIG. 46 Medical International Technology, SWOT Analysis 105 FIG. 47 Key Financials of Medical International Technology 106 FIG. 48 Medical International Technology Revenue Split, 2018 107 FIG. 49 Zosano Pharma SWOT Analysis 109 FIG. 50 Key Financials of Zosano Pharma 110 FIG. 51 Valeritas, SWOT Analysis 113 FIG. 52 Key Financials of Valeritas 114 FIG. 53 Valeritas Revenue Split, 2018 115 FIG. 54 3M SWOT Analysis 118 FIG. 55 Key Financials of 3M 118 FIG. 56 3M Revenue Split, 2018 119 FIG. 57 Medtronic Plc SWOT Analysis 122TABLE 1 Global Needle Free Drug Delivery Device Market by Region, 2018-25 (US$ Million) 21 TABLE 2 Guidelines of Using Needle Free Devices 26 TABLE 3 Examples of Prefilled Needle-Free Devices 37 TABLE 4 Global Prefilled Needle-Free Injection System by Region, 2018-25 (US$ Million) 38 TABLE 5 Global Fillable Needle Free Injection System by Region, 2018-25 (US$ Million) 38 TABLE 6 Global Jet Injector Market Size by Region, 2018-25 (US$ Million) 41 TABLE 7 Global Transdermal Drug Delivery Systems, by Region, 2018-25 (US$ Million) 42 TABLE 8 Global Inhaler Technology by Region, 2018-25 (US$ Million) 43 TABLE 9 Global Needle-Free Insulin Delivery Market by Region, 2018-25 (US$ Million) 46 TABLE 10 Global Needle-Free Vaccination Market by Region, 2018-25 (US$ Million) 47 TABLE 11 Global Needle-Free Paediatric Injection Market by Region, 2018-25 (US$ Million) 48 TABLE 12 Global Needle-Free Pain Management Market, by Region, 2018-25 (US$ Million) 49 TABLE 13 Specification of Needle-Free Devices By Injection Methods 51 TABLE 14 Global Needle-Free Powdered Injection Market by Region, 2018-25 (US$ Million) 52 TABLE 15 Examples of Drugs Administered via Liquid Jet Injector 52 TABLE 16 Global Needle-Free Liquid Injection Market by Region, 2018-25 (US$ Million) 53 TABLE 17 Global Needle-Free Depot or Projectile Injection Market by Region, 2018-25 (US$ Million) 53 TABLE 18 Global Needle-Free Spring Loaded Jet Injector Market by Region, 2018-25 (US$ Million) 55 TABLE 19 Global Needle-Free Gas Powered Jet Injector Market by Region, 2018-25 (US$ Million) 56 TABLE 20 Global Needle-Free Battery Powered Jet Injector Market by Region, 2018-25 (US$ Million) 57 TABLE 21 North America Needle Free Drug Delivery Device by Product 2018-25 (US$ Million) 61 TABLE 22 North America Needle-Free Drug Delivery Device by Technology, 2018-25 (US$ Million) 61 TABLE 23 North America Needle-Free Drug Delivery Device by Application,2018-2025 (US$ Million) 62 TABLE 24 North America Needle-Free Drug Delivery Device by Injection Method, 2018-25 (US$ Million) 62 TABLE 25 North America Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (US$ Million) 63 TABLE 26 Europe Needle-Free Drug Delivery Device by Product, 2018-25 (US$ Million) 67 TABLE 27 Europe Needle-Free Drug Delivery Device by Technology, 2018-25 (US$ Million) 67 TABLE 28 Europe Needle-Free Drug Delivery Device by Application,2018-2025 (US$ Million) 68 TABLE 29 Europe Needle-Free Drug Delivery Device by Injection Method, 2018-25 (US$ Million) 68 TABLE 30 Europe Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (US$ Million) 69 TABLE 31 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in Asia-Pacific 70 TABLE 32 Asia Pacific Needle-Free Drug Delivery Device by Product, 2018-25 (US$ Million) 73 TABLE 33 Asia Pacific Needle-Free Drug Delivery Device by Technology, 2018-25 (US$ Million) 73 TABLE 34 Asia Pacific Needle-Free Drug Delivery Device by Application, 2018-2025 (US$ Million) 74 TABLE 35 Asia Pacific Needle-Free Drug Delivery Device by Injection Method, 2018-25 (US$ Million) 74 TABLE 36 Asia Pacific Needle-Free Drug Delivery Device by Source of Power, 2018-25 (US$ Million) 75 TABLE 37 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in RoW 76 TABLE 38 RoW Needle-Free Drug Delivery Device Market by Product, 2018-25 (US$ Million) 77 TABLE 39 RoW Needle-Free Drug Delivery Device Market by Technology, 2018-25 (US$ Million) 77 TABLE 40 RoW Needle-Free Drug Delivery Device Market by Application,2018-2025 (US$ Million) 78 TABLE 41 RoW Needle-Free Drug Delivery Device Market by Injection Method, 2018-25 (US$ Million) 78 TABLE 42 RoW Needle-Free Drug Delivery Device Market by Source of Power, 2018-25 (US$ Million) 79 TABLE 43 Antares Pharma Inc. Key Facts 84 TABLE 44 Product segmentation of Antares Pharma Inc. 85 TABLE 45 Antares Pharma, Inc. Growth Strategy 85 TABLE 46 Revenue Split 87 TABLE 47 Consort Medical Key Facts 89 TABLE 48 Product segmentation of Consort Medical 90 TABLE 49 Consort Medical Growth Strategy 90 TABLE 50 Crossject Société Key Facts 94 TABLE 51 Product segmentation of Crossject Société Anonyme 94 TABLE 52 Crossject Société Anonyme Growth Strategy 95 TABLE 53 Inovio Pharmaceutical Key Facts 96 TABLE 54 Product segmentation of Inovio Pharmaceuticals 97 TABLE 55 Inovio Pharmaceuticals Growth Strategy 98 TABLE 56 Injex Pharma Key Facts 101 TABLE 57 Product segmentation of Injex Pharma 101 TABLE 58 Injex Pharma Growth Strategy 102 TABLE 59 Medical International Technology Key Facts 103 TABLE 60 Product segmentation of Medical International Technology 104 TABLE 61 Medical International Technology Growth Strategy 104 TABLE 62 Revenue Split 106 TABLE 63 Zosano Pharma Key Facts 107 TABLE 64 Product segmentation of Zosano Pharma 108 TABLE 65 Zosano Pharma Growth Strategy 108 TABLE 66 Valeritas Key Facts 111 TABLE 67 Product segmentation of Valeritas 112 TABLE 68 Valeritas Growth Strategy 112 TABLE 69 3M Key Facts 115 TABLE 70 Product segmentation of 3M 116 TABLE 71 3M Growth Strategy 116 TABLE 72 PharmaJet Key Facts 120 TABLE 73 Product segmentation of PharmaJet 121 TABLE 74 Pharmajet Growth Strategy 121

Antares Pharma, Inc., Consort Medical, Crossject Société Anonyme, Crossject Société Anonyme, Injex Pharma, Medical International Technology, Zosano Pharma, Valeritas, 3M, PharmaJet